Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ALLERFED

PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

Standard Dose
60MG;2.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ALLERFED is listed in Drugs@FDA under application 088860 (ANDA).

Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE Form and strength TABLET;ORAL - 60MG;2.5MG Sponsor PVT FORM Submission history Latest submission status date: 1985-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALLERFED is listed in Drugs@FDA under application 088860 (ANDA). Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE Form and strength TABLET;ORAL - 60MG;2.5MG Sponsor PVT FORM Submission history Latest submission status date: 1985-01-31 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ALLERFED (PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline